- Home
- ABLV vs MODD Comparison
ABLV vs MODD Comparison
Compare ABLV & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- MODD
- Stock Information
- Founded
- ABLV 2015
- MODD 1998
- Country
- ABLV China
- MODD United States
- Employees
- ABLV N/A
- MODD N/A
- Industry
- ABLV
- MODD Industrial Specialties
- Sector
- ABLV
- MODD Health Care
- Exchange
- ABLV Nasdaq
- MODD Nasdaq
- Market Cap
- ABLV 38.1M
- MODD 35.5M
- IPO Year
- ABLV N/A
- MODD N/A
- Fundamental
- Price
- ABLV $0.90
- MODD $1.04
- Analyst Decision
- ABLV
- MODD
- Analyst Count
- ABLV 0
- MODD 0
- Target Price
- ABLV N/A
- MODD N/A
- AVG Volume (30 Days)
- ABLV 227.8K
- MODD 113.8K
- Earning Date
- ABLV 01-01-0001
- MODD 02-13-2025
- Dividend Yield
- ABLV N/A
- MODD N/A
- EPS Growth
- ABLV N/A
- MODD N/A
- EPS
- ABLV N/A
- MODD N/A
- Revenue
- ABLV $130,087,189.00
- MODD N/A
- Revenue This Year
- ABLV N/A
- MODD N/A
- Revenue Next Year
- ABLV N/A
- MODD N/A
- P/E Ratio
- ABLV N/A
- MODD N/A
- Revenue Growth
- ABLV N/A
- MODD N/A
- 52 Week Low
- ABLV $0.55
- MODD $0.68
- 52 Week High
- ABLV $2.43
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- ABLV 46.90
- MODD 50.69
- Support Level
- ABLV $0.83
- MODD $1.05
- Resistance Level
- ABLV $0.99
- MODD $1.16
- Average True Range (ATR)
- ABLV 0.16
- MODD 0.11
- MACD
- ABLV -0.02
- MODD 0.02
- Stochastic Oscillator
- ABLV 13.11
- MODD 44.44
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.